bibliographic resource 8212786 [br/8212786]
https://w3id.org/oc/corpus/br/8212786
- is a
-
- title
-
- Faculty of 1000 evaluation for Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study.
- publication date
-
- contributor
-
- identifier
-
- part of
-